Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00805935 · ClinicalTrials.gov registry record · Phase 4
Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)
A Phase 4 study, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 110
- Enrollment target
NCT00805935 is a Phase 4 study that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 110 participants.
The verdict
NCT00805935, a Phase 4 study, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 110 participants
- Enrollment target
Study Summary
This multicenter, randomized, open-label exploratory study will be performed in approximately 200 polycystic ovary syndrome (PCOS) but otherwise healthy females undergoing in vitro fertilization (IVF). Each study center will follow its standard practice for in vitro fertilization (IVF) within the study parameters as noted in this protocol. The study centers will use marketed products purchased from Schraft's Pharmacy for all phases of the study (down-regulation, stimulation, ovulation induction, and luteal support). Subjects will be randomly assigned to highly purified menotropin (Menopur®) or follitropin beta (Follistim Pen®) for stimulation and progesterone vaginal insert (Endometrin®) or progesterone in oil for luteal support. Subjects will return to the study center for regular scheduled clinic visits as required per in vitro fertilization (IVF) protocol at the site and at specified times during the cycle (Stimulation Day 6, Day of human chorionic gonadotropin (hCG), and first serum pregnancy test) for estradiol (E2), progesterone (P4) and human chorionic gonadotropin (hCG) labs. All subjects will be required to complete a final study visit at completion of luteal support or negative serum pregnancy test following embryo transfer.
Interventions
- DRUG leuprolide acetate
- DRUG Menotropin
- DRUG Progesterone vaginal insert
- DRUG Follitropin beta
- DRUG Progesterone in oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00805935
The ClinicalTrials.gov registry entry for NCT00805935 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ferring Pharmaceuticals, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which leuprolide acetate is the first listed.
NCT00805935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00805935 about?
NCT00805935 is a clinical study titled "Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)". This multicenter, randomized, open-label exploratory study will be performed in approximately 200 polycystic ovary syndrome (PCOS) but otherwise healthy females undergoing in vitro fertilization (IVF). Each study center will follow its standard practice for in vitro fertilization (IVF) within the st...
What is the current status of trial NCT00805935?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 110 participants. The study started on 2009-01. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00805935?
The interventions under investigation include: leuprolide acetate (DRUG), Menotropin (DRUG), Progesterone vaginal insert (DRUG), Follitropin beta (DRUG), Progesterone in oil (DRUG).
Who is sponsoring clinical trial NCT00805935?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.